Fundraising Fox
/Companies
Sign in

Lazzaromed

Boulder, US · Founded 2019 · 2 known investors

Find your way into Lazzaromed

Sign up to see every warm intro you have to Lazzaromed

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Lazzaromed team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Lazzaro Medical develops a minimally invasive robotic surgery for repairing tracheobronchomalacia (TBM), a degenerative airway disease, using an implantable scaffold system as an alternative to risky open surgery. Its offering also includes diagnostic tools and surgical training programs for hospitals, thoracic surgeons, otolaryngologists, and pulmonologists.

BiotechHealthtechMedical DevicesRobotics

Founders & leadership

Lazzaromed was founded in 2019 by Richard S. Lazzaro, M.D..

RSRichard S. Lazzaro, M.D.
Richard S. Lazzaro, M.D.Co-FounderRichard Lazzaro is a physician with background in thoracic surgery and experience in hospital leadership and business development.
DDD. Dawn Bitz
D. Dawn BitzPresidentD. Dawn Bitz has spent 29+ years in healthcare leadership, holding CEO roles at public, venture-backed, and emerging-growth companies with P&L responsibility exceeding $500M across medical devices, respiratory care, diagnostics, and digital health. Her experience spans strategy, operations, commercialization, R&D, regulatory, manufacturing, and M&A across the healthcare sector.
RJRobert J. Wiesenberg
Robert J. WiesenbergChief Operating OfficerMr. Wiesenberg is the Chief Operating Officer of the Issuer. at Lazzaro Medical
RG
Ryan G. RedfordMr. Redford is the Chief Technology Officer of the Issuer.
FJFrederick J. Onorato
Frederick J. OnoratoFractional Legal CounselMr. Onorato is the Secretary of the Issuer. at Lazzaro Medical
JRJames R. Polsen
James R. PolsenExecutiveExecutive Officer at Lazzaro Medical
RA
Robert A. IsraelNamed on SEC filing

Investors · 2

Device of Tomorrow Capitallisted by Device of Tomorrow Capital

Reported raises · per SEC filings

Form D private placements

$4.9M disclosed across 1 round · 2022

▶$4.9MraisedJul 2024 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert A. IsraelDirector, Executive Officer, Promoter
  • Richard S. Lazzaro, M.D.Director, Executive Officer, Promoter
  • D. Dawn BitzExecutive Officer
  • Robert J. WiesenbergExecutive Officer
  • Ryan G. RedfordExecutive Officer
  • Frederick J. OnoratoExecutive Officer
  • James R. PolsenExecutive Officer
Offering amount
$7.5M
Amount sold
$4.9M
First sale
Feb 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Lazzaromed do?
Lazzaro Medical develops a minimally invasive robotic surgery for repairing tracheobronchomalacia (TBM), a degenerative airway disease, using an implantable scaffold system as an alternative to risky open surgery. Its offering also includes diagnostic tools and surgical training programs for hospitals, thoracic surgeons, otolaryngologists, and pulmonologists.
Who founded Lazzaromed?
Lazzaromed was founded by Richard S. Lazzaro, M.D. in 2019.
Who are Lazzaromed's investors?
Lazzaromed's investors include Colorado BioScience Association, Device of Tomorrow Capital.
How much funding has Lazzaromed raised?
Lazzaromed has disclosed $4.9M raised across 1 round.
Where is Lazzaromed headquartered?
Lazzaromed is headquartered in Boulder, US.